Related Experiment Video
Updated: Dec 20, 2025
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.4K
Management of Noncutaneous Melanomas
1Department of Surgery, NYU Langone Health, 550 1st Avenue, NBV 15N1, New York, NY 10016, USA.
Surgical Oncology Clinics of North America
|June 3, 2020
Summary
Noncutaneous melanomas are rare and aggressive cancers. Early diagnosis is often delayed due to amelanotic presentation, and treatment lacks standardized protocols, necessitating further research into effective therapies.
Area of Science:
- Oncology
- Dermatology
- Pathology
Background:
- Noncutaneous melanomas are rare melanoma subtypes with poor prognosis.
- Amelanotic presentation in 33-50% of cases can delay diagnosis.
- Current diagnostic and staging methods lack standardization.
Purpose of the Study:
- To review the characteristics of noncutaneous melanomas.
- To discuss diagnostic challenges and current management strategies.
- To highlight areas for future research in noncutaneous melanoma.
Main Methods:
- Literature review of noncutaneous melanoma cases.
- Analysis of diagnostic methods including immunohistochemistry.
- Evaluation of current staging and treatment options.
Main Results:
- Immunohistochemistry aids in diagnosing amelanotic noncutaneous melanomas.
- No standard staging system exists for mucosal melanomas.
- Limited data supports elective nodal dissection or sentinel lymph node biopsy.
Conclusions:
- Noncutaneous melanomas require timely diagnosis and tailored treatment approaches.
- Mutational analysis is recommended for all patients.
- Systemic therapies including targeted therapy, immunotherapy, and chemotherapy show promise but require further investigation.
